BUD31 and ovarian carcinoma: To further explore the function of BUD31 in ovarian cancer, we performed an EdU (5-ethynyl-2′-deoxyuridine) assay and found that BUD31 overexpression in HEYA8, A2780 and OVCAR3 cells significantly increased the number of EdU-positive cells.